Global pricing assessment and forecast

• Life Sciences
• CRA Insights

Part 4: Inflation Reduction Act: The indirect effects and implications of IRA price negotiations

Since passage of the Inflation Reduction Act (IRA) in August 2022, the focus of many industry analysts and pharmaceutical companies has been on two important...

• Life Sciences
• CRA Insights

France: A step towards more regulated drug prices

2022 was an expensive year for public spending in France, that led to a €18.9 billion debt for the social security system[1], of which almost 90% was driven by...

• Life Sciences
• Sponsorship & Speaking Engagement

• July 26-27, 2023
• Omni Parker House, Boston

ACI's Women Leaders in Life Sciences Law

Rajini Jayasuriya is a panelist on “Life Sciences Around the Globe: Exploring Key International Developments Impacting the Global Life Sciences Stage” and will...